Sleep Patterns in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
Author Information
Author(s): Sofia Schaeffer, Andrijana Bogdanovic, Talitha Hildebrandt, Emilio Flint, Anne Geng, Sylvia Pecenko, Paul Lussier, Michael A. Strumberger, Martin Meyer, Jakob Weber, Markus H. Heim, Christian Cajochen, Christine Bernsmeier
Primary Institution: University of Basel, Basel, Switzerland
Hypothesis
Does metabolic dysfunction-associated steatotic liver disease (MASLD) affect sleep patterns compared to healthy controls?
Conclusion
Patients with MASLD experience fragmented nocturnal sleep characterized by increased wakefulness and reduced sleep efficiency.
Supporting Evidence
- Patients with MASLD had more awakenings per night compared to healthy controls.
- Patients with MASLD reported shorter sleep duration and poorer sleep quality.
- Standardized sleep hygiene education did not improve sleep parameters.
Takeaway
People with a liver disease called MASLD have trouble sleeping well, waking up more often at night and feeling less rested.
Methodology
The study used actigraphy to objectively assess sleep-wake rhythms in 35 patients with biopsy-proven MASLD and 16 healthy controls over 4 weeks.
Potential Biases
Self-reported sleep data may be subject to reporting bias.
Limitations
The study had a small sample size and potential confounding factors such as BMI differences and undetected obstructive sleep apnea.
Participant Demographics
Participants included 35 patients with MASLD and 16 healthy controls, with a median age of 58 years for MASLD patients.
Statistical Information
P-Value
0.0036
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website